Fasudil, a Rock inhibitor, blocks the VEGF/Src/Cav-1/signaling pathway to alleviate renal inflammation, glomerulosclerosis, and proteinuria in diabetic mice (Xie et al., 2013; Jin et al., 2015). Here, CAV1 is linked to glomerulosclerosis.